3,448 results on '"Goldman, R."'
Search Results
52. Recursive Triangles
53. The Effects of the Serious Illness Care Program (SICP) on Health Care Resource Utilization (HRU)
54. On the smoothness of real-valued functions generated by subdivision schemes using nonlinear binary averaging
55. Non-uniform subdivision for B-splines of arbitrary degree
56. Influence of surface nano-patterning on the placement of InAs quantum dots.
57. Cell Cycle-Dependent Changes in the Organization of an Intermediate Filament-Associated Protein: Correlation with Phosphorylation by p34 cdc2
58. A Rapid Procedure for Preparing Fluorescein-Labeled Specific Antibodies from Whole Antiserum: Its Use in Analyzing Cytoskeletal Architecture
59. Influence of gallium surface saturation on GaN nanowire polytype selection during molecular-beam epitaxy
60. OP0289 LLDAS (LOW LUPUS DISEASE ACTIVITY STATE), LOW DISEASE ACTIVITY (LDA) AND REMISSION (ON- OR OFF-TREATMENT) PREVENT DAMAGE ACCRUAL IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS IN A MULTINATIONAL MULTICENTER COHORT
61. Abstract No. 534 Evolving role of radiology in performing basic procedures for Medicare beneficiaries from 1996 to 2018
62. Abstract No. 568 Interpretation of diagnostic vascular imaging studies for Medicare patients by interventional radiologists: a comparison to other specialties and implications for interventional radiology
63. Abstract No. 472 Alternate venous access sites for ported catheters: experience at a single quaternary care institution
64. Expectations of Patients Seen in the Emergency Department for SARS-CoV-2 During the Pandemic
65. European League against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
66. Global epidemiology of systemic lupus erythematosus.
67. Publisher Correction: Global epidemiology of systemic lupus erythematosus (Nature Reviews Rheumatology, (2021), 17, 9, (515-532), 10.1038/s41584-021-00668-1).
68. Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (vol 18, pg 1304, 2021)
69. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus
70. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis
71. Linking computational and experimental studies of III–V quantum dots for optoelectronics and photovoltaics
72. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort
73. Nonlinear subdivision through nonlinear averaging
74. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing
75. Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population
76. Genetic associations of LYN with systemic lupus erythematosus
77. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans
78. Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: Pooled analysis of double-blind, placebo-controlled 6-week studies
79. Lurasidone in adolescents with schizophrenia: Sustained remission and recovery during 2 years of open-label treatment
80. Two blossoming proofs of the Lane-Riesenfeld algorithm
81. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities
82. Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities
83. PERFORMANCE OF THE EULAR/ACR 2019 CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN EARLY DISEASE, ACROSS SEXES AND ETHNICITIES
84. Systemic Lupus Erythematosus
85. Lung cancer in systemic lupus erythematosus
86. Formation of embedded plasmonic Ga nanoparticle arrays and their influence on GaAs photoluminescence.
87. P.855Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: pooled analysis of double-blind, placebo-controlled 6-week studies
88. P.560 Lurasidone in adolescents with schizophrenia: remission and recovery during 2 years of open-label treatment
89. P.323 Assessing the benefit-risk ratio of approved treatments for bipolar depression using likelihood to be helped or harmed (LHH) analyses
90. P.325 Effect of lurasidone on manic symptoms and treatment-emergent mania in adult and pediatric populations with bipolar depression
91. DONOR SELECTION FOR RECIPIENT SAFETY: 1C-H06-02
92. Lymphoma Risk in Systemic Lupus: Effects of Disease Activity Versus Treatment.: 2570
93. FREQUENCY AND RISK FACTORS FOR DONOR REACTIONS: 5C-S40–03
94. Prostate cancer in systemic lupus erythematosus
95. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus
96. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus
97. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA
98. Influence of electron irradiation and rapid thermal annealing on photoluminescence from GaAsNBi alloys
99. Influence of quantum dot morphology on the optical properties of GaSb/GaAs multilayers
100. THU0271 PERFORMANCE OF THE EULAR/ACR 2019 CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN EARLY DISEASE, ACROSS SEXES AND ETHNICITIES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.